{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:33:33Z","timestamp":1790127213967,"version":"4.0.1"},"reference-count":35,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1825,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1111\/j.1742-7843.2010.00628.x","type":"journal-article","created":{"date-parts":[[2010,9,3]],"date-time":"2010-09-03T20:47:40Z","timestamp":1283546860000},"page":"55-62","source":"Crossref","is-referenced-by-count":86,"title":["Stereo-Selective Metabolism of Methadone by Human Liver Microsomes and cDNA-Expressed Cytochrome P450s: A Reconciliation"],"prefix":"10.1111","volume":"108","author":[{"given":"Yan","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfang B.","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen-Nan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Moody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,9,2]]},"reference":[{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0024-3205(94)00937-6","article-title":"The mu1, mu 2, delta, kappa opioid receptor binding properties of methadone stereoisomers and morphine","volume":"56","author":"Kristensen","year":"1995","journal-title":"Life Sci"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0022-3565(25)03418-4","article-title":"Pharmacological comparison of the optical isomers of methadone","volume":"92","author":"Scott","year":"1948","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/00007691-199606000-00001","article-title":"Stereoselective pharmacokinetics of methadone in chronic pain patients","volume":"18","author":"Kristensen","year":"1996","journal-title":"Ther Drug Monit"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1046\/j.1365-2125.2000.00272.x","article-title":"Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients","volume":"50","author":"Foster","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/jat\/32.3.208","article-title":"An enantiomer selective liquid chromatography-tandem mass spectrometry method for methadone and EDDP validated for use in human plasma, urine and liver microsomes","volume":"32","author":"Moody","year":"2008","journal-title":"J Anal Toxicol"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1749-6632.1976.tb27945.x","article-title":"Drug interactions with methadone","volume":"281","author":"Kreek","year":"1976","journal-title":"Ann NY Acad Sci"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","article-title":"Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence","volume":"41","author":"Eap","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.phrs.2004.05.002","article-title":"Methadone - metabolism, pharmacokinetics and interactions","volume":"50","author":"Ferrari","year":"2004","journal-title":"Pharmacol Res"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1521-0391.2009.00005.x","article-title":"Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review","volume":"19","author":"McCance-Katz","year":"2010","journal-title":"Am J Addict"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/sj.clpt.6100120","article-title":"Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers","volume":"81","author":"Eap","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1021\/tx950116m","article-title":"Involvement of cytochrome P450 3A4 enzyme in the N-demethylation of methadone in human liver microsomes","volume":"9","author":"Iribarne","year":"1996","journal-title":"Chem Res Toxicol"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB12|cit12","first-page":"1347","article-title":"The involvement of cytochrome P450 3A in the N-demethylation of l-\u03b1-acetylmethadol (LAAM), norLAAM and methadone","volume":"25","author":"Moody","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-2125.1999.00921.x","article-title":"Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4","volume":"47","author":"Foster","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/elps.200305493","article-title":"Capillary electrophoresis to assess drug metabolism induced in vitro using single CYP450 enzymes (Supersomes\u2122): Application to the chiral metabolism of mephenytoin and methadone","volume":"24","author":"Prost","year":"2003","journal-title":"Electrophoresis"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1124\/dmd.31.6.742","article-title":"Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro","volume":"31","author":"Wang","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/chir.10303","article-title":"Stereoselective metabolism of methadone N-demethylation by cytochrome P4502B6 and 2C19","volume":"16","author":"Gerber","year":"2004","journal-title":"Chirality"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.clpt.2004.05.003","article-title":"Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone","volume":"76","author":"Kharasch","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/jpet.106.117580","article-title":"Enantiomeric interactions and stereoselective human methadone metabolism","volume":"321","author":"Totah","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/ALN.0b013e3181642938","article-title":"Role of CYP2B6 in stereoselective human methadone metabolism","volume":"108","author":"Totah","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1006\/bbrc.2001.5054","article-title":"Differential N-demethylation of l-\u03b1-acetylmethadol (LAAM) and norLAAM by cytochrome P450s 2B6, 2C18, and 3A4","volume":"284","author":"Neff","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0090-9556(24)14891-X","article-title":"Eight inhibitory monoclonal antibodies define the role of individual P-450s in human liver microsomal diazepam, 7-ethoxycoumarin, and imipramine metabolism","volume":"27","author":"Yang","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0090-9556(24)13680-X","article-title":"Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between approaches","volume":"28","author":"Venkatakrishnan","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2125.2000.00175.x","article-title":"In vitro inhibition of the cytochrome P450 (CYP450) system by the antiplatelet drug ticlopidine: potent effect on CYP2C19 and CYP2D6","volume":"49","author":"Ko","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1124\/jpet.103.056127","article-title":"Potent mechanism-based inhibition of human CYP2B6 by clopidogrel and ticlopidine","volume":"308","author":"Richter","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1124\/dmd.32.6.626","article-title":"Selective inhibition of CYP2B6-catalyzed bupropion hydroxylation in human liver microsomes in vitro","volume":"32","author":"Turpeinen","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1124\/dmd.107.015883","article-title":"A comparison of 2-phenyl-2-(1-piperidinyl)propane (PPP), 1,1\u2019,1\u2019\u2019-phosphinothioylidynetrisaziridine (ThioTEPA), clopidogrel, and ticlopidine as selective inactivators of human cytochrome P450 2B6","volume":"35","author":"Walsky","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/00008571-199706000-00001","article-title":"Examination of purported probes of human CYP2B6","volume":"7","author":"Ekins","year":"1997","journal-title":"Pharmacogenetics"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB28|cit28","first-page":"390","article-title":"Orphenadrine and methimazole inhibit multiple cytochrome P450 enzymes in human liver microsomes","volume":"25","author":"Guo","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.clpt.2005.08.011","article-title":"Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment","volume":"78","author":"Crettol","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.clpt.2006.09.012","article-title":"ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment","volume":"80","author":"Crettol","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2125.2008.03312.x","article-title":"Contribution of the activities of CYP3A, CYP2D6, CYP1A2 and other potential covariates to the disposition of methadone in patients undergoing methadone maintenance treatment","volume":"67","author":"Shiran","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00004714-200104000-00016","article-title":"Cytochrome P450 2D6 genotype and methadone steady-state concentrations","volume":"21","author":"Eap","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/clpt.2008.104","article-title":"Mechanism of ritonavir changes in methadone pharmacokinetics and pharmacodynamics: I. Evidence against CYP3A mediation of methadone clearance","volume":"84","author":"Kharasch","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/ALN.0b013e3181986a9a","article-title":"Methadone pharmacokinetics are independent of cytochrome P4503A (CYP3A) activity and gastrointestinal drug transport","volume":"110","author":"Kharasch","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1742-7843.2010.00628.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1124\/dmd.107.016089","article-title":"Cytochrome P450 enzymes and transporters induced by anti-human immunodeficiency virus protease inhibitors in human hepatocytes: implications for predicting clinical drug interactions","volume":"35","author":"Dixit","year":"2007","journal-title":"Drug Metab Dispos"}],"container-title":["Basic &amp; Clinical Pharmacology &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-7843.2010.00628.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T14:29:22Z","timestamp":1740493762000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-7843.2010.00628.x"}},"subtitle":["IN VITRO METABOLISM OF METHADONE"],"short-title":[],"issued":{"date-parts":[[2010,9,2]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1742-7843.2010.00628.x","relation":{},"ISSN":["1742-7835"],"issn-type":[{"value":"1742-7835","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9,2]]}}}